Otros idiomas Zhejiang Orient Gene Biotech Co.,Ltd

Acciones

688298

CNE100003RM8

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
27,76 ^CNY	+1,87 %		+5,47 %	-22,37 %

28/02	Zhejiang Orient Gene Biotech Co.,Ltd informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI
08/02	Zhejiang Orient Gene Biotech Co.,Ltd (SHSE:688298) anuncia una recompra de acciones por valor de 100 millones de CNY.	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Zhejiang Orient Gene Biotech's Unit Gets US FDA's Nod to Register Two Products	23/04
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Zhejiang Orient Gene Biotech Co.,Ltd announces an Equity Buyback for CNY 100 million worth of its shares.	08/02
Zhejiang Orient Gene Biotech Co.,Ltd authorizes a Buyback Plan.	07/02
Zhejiang Orient Gene Obtains Veterinary GMP Certificate, Production License	08/01
Zhejiang Orient Gene Biotech Co.,Ltd(SHSE:688298) dropped from Shanghai Stock Exchange Health Care Sector Index	08/12
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Orient Gene Biotech Registers New In Vitro Diagnostic Reagents	13/07/23
Zhejiang Orient Gene Biotech Elects Chairman, Vice Chairman	01/06/23
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Zhejiang Orient Gene Registers Two Medical Devices in EU, US	24/03/23
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
IN BRIEF: Omega Diagnostics receives CD4 deferred consideration	25/11/22
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Omega Diagnostics Up 16% With Sale Of Loss-Making CD4 Business	03/08/22
ZXBio, Inc. announced that it has received $3.1 million in funding from Zhejiang Orient Gene Biotech Co., Ltd.	08/06/22
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Zhejiang Orient Gene Biotech Co.,Ltd

Acciones

688298

CNE100003RM8

Otros idiomas

Filtros